The DOI matches its Crossref record; 109 of the 110 references it cites were found in a registry or an index.
Ironing out Ferroportin
Open accessAbstract
Maintaining physiologic iron concentrations in tissues is critical for metabolism and host defense. Iron absorption in the duodenum, recycling of iron from senescent erythrocytes, and iron mobilization from storage in macrophages and hepatocytes constitute the major iron flows into plasma for distribution to tissues, predominantly for erythropoiesis. All iron transfer to plasma occurs through the iron exporter ferroportin. The concentration of functional membrane-associated ferroportin is controlled by its ligand, the iron-regulatory hormone hepcidin, and fine-tuned by regulatory mechanisms serving iron homeostasis, oxygen utilization, host defense, and erythropoiesis. Fundamental questions about the structure and biology of ferroportin remain to be answered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Aberrant ferroportin activity can lead to diseases of iron overload, like hemochromatosis, or iron limitation anemias 2 .”
From Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms (2020) · cites this paper as [2]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In mammals, iron levels are regulated by the action of hepcidin, a peptide hormone, on ferroportin (FPN), the only known iron efflux transporter 2-4 (Fig. 1a).”
From Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms (2020) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“The cryo-EM density map of FPN enabled building of an atomic model of FPN regions important for iron transport and hepcidin binding 2,7 , and a portion of the intracellular loop 3 (ICL3) important in hepcidin-induced FPN internalization 8-10 (Extended Data Fig. 5).”
From Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms (2020) · cites this paper as [2]
In the citing paper
“The expression of FPN is tightly regulated at the transcriptional, posttranscriptional, and posttranslational levels.8”
From RNF217 regulates iron homeostasis through its E3 ubiquitin ligase activity by modulating ferroportin degradation (2021) · cites this paper as [8]
In the citing paper
“In duodenal enterocytes, transcription of the Fpn gene, which encodes ferroportin, is regulated by iron and hypoxia to increase the absorption of dietary iron during iron deficiency and anemia.8,54”
From RNF217 regulates iron homeostasis through its E3 ubiquitin ligase activity by modulating ferroportin degradation (2021) · cites this paper as [8]
In the citing paper
“Taken together, these data support that FPN expression is tightly controlled at both transcriptional and/or the translational levels,8,68,69 which allow multiple and diverse physiological effects to influence FPN activity at its various sites of expression.”
From RNF217 regulates iron homeostasis through its E3 ubiquitin ligase activity by modulating ferroportin degradation (2021) · cites this paper as [8]
In the citing paper
“On average, humans ingest 20–25 mg of iron/day, the majority of which is inorganic iron (85%–90%), followed by haem‐bound iron (10%–15%).”
From The battle for iron in enteric infections (2020) · cites this paper as [9]
In the citing paper
“In mammals, excretion of iron is not extensively regulated; instead, iron homeostasis is achieved mainly by regulating intestinal absorption in the duodenum, 9 and possibly in the colon to some extent. 10”
From The battle for iron in enteric infections (2020) · cites this paper as [9]
In the citing paper
“However, only ~ 1 mg iron is absorbed per day, because of both poor iron bioavailability and tightly regulated iron homeostasis. 9 , 11”
From The battle for iron in enteric infections (2020) · cites this paper as [9]
In the citing paper
“In conditions of iron accumulation, the production of HAMP is stimulated, and, as a result, iron is subsequently trapped within enterocytes and macrophages, respectively inhibiting iron export to circulation or preventing recycling of iron derived from red blood cells. 9”
From The battle for iron in enteric infections (2020) · cites this paper as [9]
In the citing paper
“The iron regulatory hormone hepcidin limits iron fluxes to the bloodstream by promoting degradation of the iron exporter ferroportin in target cells.”
From Pharmacological Targeting of the Hepcidin/Ferroportin Axis (2016) · cites this paper as Drakesmith et al., 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
RETRACTED: The Hepcidin-Binding Site on Ferroportin Is Evolutionarily Conserved
Domenico, I. D., Nemeth, E., Nelson, J. M., Phillips, J. D., Ajioka, R. S., Kay, M. S., Kushner, J. P., Ganz, T., Ward, D. M., & Kaplan, J. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.07.002 · Cited by 127
Self-citationRetractedDomenico, I. D., Lo, E., Yang, B., Korolnek, T., Hamza, I., Ward, D. M., & Kaplan, J. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.09.008 · Cited by 27
RetractedExploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803
Self-citationPositional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter
Donovan, A., Brownlie, A., Zhou, Y., Shepard, J., Pratt, S. J., Moynihan, J., Paw, B. H., Drejer, A., Barut, B., Zapata, A., et al. (2000) · Nature · doi:10.1038/35001596 · Cited by 1,667
McKie, A. T., Marciani, P., Rolfs, A., Brennan, K., Wehr, K., Barrow, D., Miret, S., Bomford, A., Peters, T. J., Farzaneh, F., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80425-6 · Cited by 1,422
Dysmetabolic Hyperferritinemia: All Iron Overload Is Not Hemochromatosis
Makker, J. S., Hanif, A., Bajantri, B., & Chilimuri, S. S. (2015) · Case Reports in Gastroenterology · doi:10.1159/000373883 · Cited by 1,353
The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis
Donovan, A., Lima, C. A., Pinkus, J. L., Pinkus, G. S., Zon, L. I., Robine, S., & Andrews, N. C. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.01.003 · Cited by 1,275
A Novel Mammalian Iron-regulated Protein Involved in Intracellular Iron Metabolism
Abboud, S., & Haile, D. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000713200 · Cited by 1,267
Nicolas, G., Bennoun, M., Devaux, I., Beaumont, C., Grandchamp, B., Kahn, A., & Vaulont, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151179498 · Cited by 1,233
Research works printed but not linked: 2
- Altamura, 2011, Mouse models for ferroportin with impaired hepcidin regulation, Am. J. Hematol., 86, E42
- Preza, 2011, Minihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overload, J. Clin. Invest., 121, 4880, 10.1172/JCI57693 · DOI · Paper page
Cited by
Sorted by citations
Items 201–300 of 631
Epigenetic Regulation of Ferroptosis in Central Nervous System Diseases
Lan, T., Sun, T., Wei, C., Cheng, T., Yang, F., Zhang, J.-N., & Li, Q. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03267-1 · Cited by 35
Ironing out Macrophage Immunometabolism
Recalcati, S., Gammella, E., & Cairo, G. (2019) · Pharmaceuticals · doi:10.3390/ph12020094 · Cited by 35
Identification of Antibody and Small Molecule Antagonists of Ferroportin-Hepcidin Interaction
Ross, S. L., Biswas, K., Rottman, J., Allen, J. R., Long, J., Miranda, L. P., Winters, A., & Arvedson, T. L. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00838 · Cited by 33
Wei, Z., Zhang, X., Zhang, Z., Yong, T., Zhan, G., Lv, W., Ding, Z., Sun, K., Yang, X., & Gan, L. (2021) · Chemical Engineering Journal · doi:10.1016/j.cej.2021.133847 · Cited by 33
Triad role of hepcidin, ferroportin, and Nrf2 in cardiac iron metabolism: From health to disease
Jayakumar, D., Narasimhan, K. K. S., & Kalaiselvi, P. (2021) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2021.126882 · Cited by 34
Iron and Copper Deficiencies, and Disorders of Iron Metabolism
Radakovich, L. B., & Olver, C. S. (2022) · Schalm's Veterinary Hematology · doi:10.1002/9781119500537.ch27 · Cited by 33
Iron accumulation and lipid peroxidation: implication of ferroptosis in diabetic cardiomyopathy
Yan, X., Xie, Y., Liu, H., Huang, M., Yang, Z., Dong-qing, A., & Jiang, G. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01135-5 · Cited by 34
Schwartz, A. J., Converso‐Baran, K., Michele, D. E., & Shah, Y. M. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.009578 · Cited by 36
Hyperferritinaemia: An Iron Sword of Autoimmunity
Giemza-Stokłosa, J., Islam, M. A., & Kotyla, P. J. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190709202804 · Cited by 33
Iron in the Symbiosis of Plants and Microorganisms
Liu, Y., Xiong, Z., Wu, W., Ling, H., & Kong, D. (2023) · Plants · doi:10.3390/plants12101958 · Cited by 31
Targeting iron-metabolism:a potential therapeutic strategy for pulmonary fibrosis
Sun, Y., Ren, Y., Song, L., Wang, Y.-Y., Li, T., Wu, Y., Li, L., & Yang, Z. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116270 · Cited by 32
Kontoghiorghes, G. J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094654 · Cited by 34
Foka, P., Dimitriadis, A., Karamichali, E., Kyratzopoulou, E., Giannimaras, D., Koskinas, J. S., Varaklioti, A., Mamalaki, A., & Georgopoulou, U. (2016) · Virulence · doi:10.1080/21505594.2016.1175700 · Cited by 31
Ma, J., Li, R., Liu, Y., Qu, G., Liu, J. L., Guo, W., Song, H., Li, X., Liu, Y., Xia, T., et al. (2017) · Small · doi:10.1002/smll.201603830 · Cited by 31
Broadening horizons: The role of ferroptosis in myocardial ischemia–reperfusion injury
Zhao, K., Chen, X., Bian, Y.-J., Zhou, Z., Wei, X., & Zhang, J. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02506-5 · Cited by 31
Wang, Y., Du, Y., Liu, G., Guo, S., Hou, B., Jiang, X., Han, B., Chang, Y.-Z., & Nie, G. (2016) · International Journal of Hematology · doi:10.1007/s12185-016-2150-8 · Cited by 31
How does hepcidin hinder ferroportin activity?
Zhang, D., & Rouault, T. A. (2018) · Blood · doi:10.1182/blood-2018-01-824151 · Cited by 31
Pulmonary Arterial Hypertension: Iron Matters
Ramakrishnan, L., Pedersen, S. L., Toe, Q. K., Quinlan, G. J., & Wort, S. J. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00641 · Cited by 31
Yang, Y., Wang, Q., Gao, L., Liu, S., Zhao, J., Liu, G., & Zhang, S. (2023) · Cell Biology International · doi:10.1002/cbin.12029 · Cited by 31
Structures and coordination chemistry of transporters involved in manganese and iron homeostasis
Ray, S., & Gaudet, R. (2023) · Biochemical Society Transactions · doi:10.1042/bst20210699 · Cited by 31
The Effects of Iron Supplementation and Fortification on the Gut Microbiota: A Review
Finlayson-Trick, E. C., Fischer, J. A. J., Goldfarb, D. A., & Karakochuk, C. D. (2020) · Gastrointestinal Disorders · doi:10.3390/gidisord2040030 · Cited by 30
The versatile biochemistry of iron in macrophage effector functions
Behmoaras, J. V. (2020) · FEBS Journal · doi:10.1111/febs.15682 · Cited by 30
PCBP2 knockdown promotes ferroptosis in malignant mesothelioma
Yue, L., Luo, Y., Jiang, L., Sekido, Y., & Toyokuni, S. (2022) · Pathology International · doi:10.1111/pin.13209 · Cited by 30
Hortová-Kohoutková, M., Skotáková, M., Onyango, I. G., Slezáková, M., Panovský, R., Opatřil, L., Slanina, P., Zuani, M. D., Mrkva, O., Andrejčinová, I., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1110540 · Cited by 28
Ferritinophagy induced ferroptosis in the management of cancer
Liu, Y.-C., Gong, Y.-T., Sun, Q., Wang, B., Yan, Y., Chen, Y.-X., Zhang, L., Zhang, W., & Luan, X. (2023) · Cellular Oncology · doi:10.1007/s13402-023-00858-x · Cited by 30
Mechanisms and Regulation of Intestinal Iron Transport
Collins, J. F., Flores, S. R., Wang, X., & Anderson, G. J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809954-4.00060-8 · Cited by 30
Advances in Immunomodulatory Mesoporous Silica Nanoparticles for Inflammatory and Cancer Therapies
Gu, B., Zhao, Q. P., & Ao, Y. (2024) · Biomolecules · doi:10.3390/biom14091057 · Cited by 29
Daniłowicz‐Szymanowicz, L., Świątczak, M., Sikorska, K., Starzyński, R. R., Raczak, A., & Lipiński, P. (2021) · Diagnostics · doi:10.3390/diagnostics11071279 · Cited by 32
The Role of Iron in Benign and Malignant Hematopoiesis
Sinha, S., Pereira-Reis, J., Guerra, A., Rivella, S., & Duarte, D. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8155 · Cited by 29
Redox mechanism of glycerophospholipids and relevant targeted therapy in ferroptosis
Chang, S., Zhang, M., Liu, C., Li, M., Lou, Y., & Tan, H. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02654-y · Cited by 32
(Z)-ligustilide increases ferroportin1 expression and ferritin content in ischemic SH-SY5Y cells
Zhang, Y., Li, F.-M., Guo, Y., Jiang, L., Ma, J., Ke, Y., & Qian, Z. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.10.029 · Cited by 28
Low-molecular-mass iron in healthy blood plasma is not predominately ferric citrate
Dziuba, N., Hardy, J., & Lindahl, P. A. (2018) · Metallomics · doi:10.1039/c8mt00055g · Cited by 28
Gasparetto, M., Pei, S., Minhajuddin, M., Stevens, B. M., Smith, C. A., & Seligman, P. A. (2019) · Leukemia Research · doi:10.1016/j.leukres.2019.02.011 · Cited by 28
Iron Availability in Tissue Microenvironment: The Key Role of Ferroportin
Gammella, E., Correnti, M., Cairo, G., & Recalcati, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062986 · Cited by 31
Jiang, X., Zhang, C., Qi, S., Guo, S., Chen, Y., Du, E., Zhang, H., Wang, X., Liu, R., Qiao, B., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12753 · Cited by 28
UBA6 and NDFIP1 regulate the degradation of ferroportin
Traeger, L., Wiegand, S. B., Sauer, A. J., Corman, B. H. P., Peneyra, K. M., Wunderer, F., Fischbach, A., Bagchi, A., Malhotra, R. K., Zapol, W. M., et al. (2021) · Haematologica · doi:10.3324/haematol.2021.278530 · Cited by 31
Xie, P., Yang, S., Huang, Y., Zeng, C., Xin, Q., Zeng, G., Yang, S., Xia, P.-F., Tang, X., & Tang, K. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c07617 · Cited by 27
Terahertz Wave Desensitizes Ferroptosis by Inhibiting the Binding of Ferric Ions to the Transferrin
Li, X., Li, Y., Xu, J., Lu, X., Ma, S., Sun, L., Chang, C., Min, L., & Fan, C. (2025) · ACS Nano · doi:10.1021/acsnano.4c13075 · Cited by 27
Interaction between iron and omega-3 fatty acids metabolisms: where is the cross-link?
Ogłuszka, M., Lipiński, P., & Starzyński, R. R. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1862047 · Cited by 28
Pilo, F., Cilloni, D., Porta, M. G. D., Forni, G. L., Piperno, A., Santini, V., & Angelucci, E. (2022) · Leukemia Research · doi:10.1016/j.leukres.2022.106792 · Cited by 27
Andersen, A. B., Bejder, J., Bonne, T. C., SØRENSEN, H., Sørensen, H., JUNG, G., Ganz, T., Nemeth, E., Secher, N. H., Johansson, P. I., et al. (2022) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000002950 · Cited by 27
Self-citationPotential issues specific to cytotoxicity tests of cellulose nanofibrils
Moriyama, A., Ogura, I., & Fujita, K. (2022) · Journal of Applied Toxicology · doi:10.1002/jat.4390 · Cited by 27
Keap1-Nrf2 Heterodimer: A Therapeutic Target to Ameliorate Sickle Cell Disease
Chauhan, W., & Zennadi, R. (2023) · Antioxidants · doi:10.3390/antiox12030740 · Cited by 27
Chavoshinezhad, S., Beirami, E., Izadpanah, E., Feligioni, M., & Hassanzadeh, K. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115656 · Cited by 28
Mazgaj, R., Lipiński, P., Edison, E. S., Bednarz, A., Staroń, R., Haberkiewicz, O., Lenartowicz, M., Smuda, E., Jończy, A., & Starzyński, R. R. (2021) · American Journal of Hematology · doi:10.1002/ajh.26152 · Cited by 27
Membrane Transporters Involved in Iron Trafficking: Physiological and Pathological Aspects
Pasquadibisceglie, A., di Patti, M. C. B., Musci, G., & Polticelli, F. (2023) · Biomolecules · doi:10.3390/biom13081172 · Cited by 26
Iron Transport across Symbiotic Membranes of Nitrogen-Fixing Legumes
Day, D. A., & Smith, P. M. C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22010432 · Cited by 26
Apolipoprotein E deficiency induces a progressive increase in tissue iron contents with age in mice
Ma, J., Qian, C., Bao, Y., Liu, M., Ma, H., Shen, M., Li, W., Wang, J., Bao, Y.-X., Liu, Y., et al. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101865 · Cited by 27
Guan, S., Zhang, S., Liu, M., Guo, J., Chen, Y., Shen, X., Deng, X., & Lu, J. (2024) · Journal of Dairy Science · doi:10.3168/jds.2023-24490 · Cited by 26
Guan, P., Sun, Z., Luo, L.-F., Zhao, Y., Yang, S., Yu, F., Wang, N., & Ji, E. (2019) · Molecules · doi:10.3390/molecules24061184 · Cited by 27
Bonilla, D. A., Moreno, Y., Petro, J. L., Forero, D. A., Vargas-Molina, S., Odriozola-Martínez, A., Orozco, C. A., Stout, J. R., Rawson, E. S., & Kreider, R. B. (2022) · Biomedicines · doi:10.3390/biomedicines10030724 · Cited by 26
Neves, J. V., Caldas, C., Ramos, M. F., & Rodrigues, P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153940 · Cited by 25
Non-Anticoagulant Heparins Are Hepcidin Antagonists for the Treatment of Anemia
Poli, M., Asperti, M., Ruzzenenti, P., Naggi, A., & Arosio, P. (2017) · Molecules · doi:10.3390/molecules22040598 · Cited by 25
Human ferroportin mediates proton-coupled active transport of iron
Li, S., Yang, Y., & Li, W. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020001864 · Cited by 25
Attenuated succinate accumulation relieves neuronal injury induced by hypoxia in neonatal mice
Zhang, M., Cheng, Y., Zhai, Y., Cui, Y., Zhang, W., Sun, H., Xin, W., Zhou, L., Gao, X. J., Li, S., et al. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-00940-7 · Cited by 25
Sheldon, J. R., Himmel, L. E., Kunkle, D. E., Monteith, A. J., Maloney, K. N., & Skaar, E. P. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010809 · Cited by 27
Du, K., Zhou, Q. Y., Wang, Z., Mo, C., Dong, W., Wei, N., Zhong, W., You, Y., Wang, Y., & Wang, Z. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121766 · Cited by 25
What is the impact of ferroptosis on diabetic cardiomyopathy: a systematic review
Lou, X., Zhang, Y., Guo, J., Gao, L., Ding, Y., Zhuo, X., Lei, Q., Bian, J., Lei, R., Gong, W., et al. (2023) · Heart Failure Reviews · doi:10.1007/s10741-023-10336-z · Cited by 25
Ka, C., Guellec, J., Pepermans, X., Kannengiesser, C., Ged, C., Wuyts, W. A., Cassiman, D. M., de Lédinghen, V., Varet, B. R., de Kerguenec, C., et al. (2018) · Haematologica · doi:10.3324/haematol.2018.189845 · Cited by 25
Fenton Reaction in vivo and in vitro. Possibilities and Limitations
Muranov, K. O. (2024) · Biochemistry (Moscow) · doi:10.1134/s0006297924140074 · Cited by 26
Guo, C., Peng, J., Cheng, P., Yang, C., Gong, S., Zhang, L., Zhang, T., & Peng, J. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1290234 · Cited by 25
Effect of zinc depletion/repletion on intestinal iron absorption and iron status in rats
Palsa, K., Palika, R., Mashurabad, P. C., Yaduvanshi, P. S., Sharp, P., & Pullakhandam, R. (2021) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2021.108800 · Cited by 24
Ferroptosis Holds Novel Promise in Treatment of Cancer Mediated by Non-coding RNAs
Zhi, Y., Gao, L., Wang, B., Ren, W., Liang, K. X., & Zhi, K. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.686906 · Cited by 26
Biology of macrophage fate decision: Implication in inflammatory disorders
Yadav, S., Dwivedi, A., & Tripathi, A. (2022) · Cell Biology International · doi:10.1002/cbin.11854 · Cited by 26
Feng, R., Wang, D., Li, T., Liu, X., Peng, T., Liu, M., Ren, G., Xu, H., Luo, H., Lu, D., et al. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.89368 · Cited by 23
Kalainayakan, S. P., Ghosh, P., Dey, S., FitzGerald, K. E., Sohoni, S. S., Konduri, P. C., Garrossian, M., Liu, L., & Li, Z. (2019) · Scientific Reports · doi:10.1038/s41598-018-38345-1 · Cited by 23
The role of non-coding RNAs in ferroptosis regulation
Qi, R., Bai, Y., Wei, Y., Liu, N., & Shi, B. (2021) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2021.126911 · Cited by 23
Mezzanotte, M., Ammirata, G., Boido, M., Stanga, S., & Roetto, A. (2022) · Scientific Reports · doi:10.1038/s41598-022-15812-4 · Cited by 26
for the EMIL Study Group, Bernhardt, P., Kratzer, W., Schmidberger, J., Graeter, T., & Gruener, B. (2018) · BMC Research Notes · doi:10.1186/s13104-018-3212-1 · Cited by 23
Plant-Based Diets and Iron Status
Moretti, D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803968-7.00039-3 · Cited by 23
Nrf2 activators for the treatment of rare iron overload diseases: From bench to bedside
Dong, Y., Zheng, M., Ding, W., Guan, H., Xiao, J., & Li, F. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103551 · Cited by 22
Upregulation of Local Hepcidin Contributes to Iron Accumulation in Alzheimer’s Disease Brains
Chaudhary, S., Ashok, A., McDonald, D., Wise, A. S., Kritikos, A. E., Rana, N. A., Harding, C. V., & Singh, N. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210221 · Cited by 23
Charlebois, E., Fillebeen, C., Katsarou, A., Rabinovich, A., Wisniewski, K., Venkataramani, V., Michalke, B., Velentza, A., & Pantopoulos, K. (2022) · eLife · doi:10.7554/elife.81332 · Cited by 22
Piperno, A., Pelucchi, S., & Mariani, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032560 · Cited by 22
Apolipoprotein E is required for brain iron homeostasis in mice
Ma, J., Guo, Q., Shen, M., Li, W., Zhong, Q.-X., & Qian, Z. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102779 · Cited by 22
Hepcidin as a potential biomarker for blood doping
Leuenberger, N., Bulla, E. G., Salamin, O., Nicoli, R., Robinson, N., Baume, N., & Saugy, M. (2016) · Drug Testing and Analysis · doi:10.1002/dta.2122 · Cited by 22
Homéostasie du fer et autophagie
Hamaï, A., & Mehrpour, M. (2017) · médecine/sciences · doi:10.1051/medsci/20173303012 · Cited by 24
Kasprowicz, K., Ratkowski, W., Wołyniec, W., Kaczmarczyk, M., Witek, K., Żmijewski, P., Renke, M., Jastrzębski, Z., Rosemann, T. J., Nikolaidis, P. Τ., et al. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17082962 · Cited by 23
Kim, H. Y., Kwon, W. Y., Park, J. B., Lee, M., Oh, Y. J., Suh, S., Baek, Y. H., Jeong, J. S., & Yoo, Y. H. (2020) · The FASEB Journal · doi:10.1096/fj.202000790r · Cited by 22
Guellec, J., Elbahnsi, A., Tertre, M. L., Uguen, K., Gourlaouen, I., Férec, C., Ka, C., Callebaut, I., & Gac, G. L. (2019) · The FASEB Journal · doi:10.1096/fj.201901857r · Cited by 21
Jiang, H., Zeng, Y., Jiang, X., Xu, X., Zhao, L., Yuan, X., Xu, J., Zhao, M., Wu, F., & Li, G. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167210 · Cited by 21
Lanser, L., & Weiß, G. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-92033-2_13 · Cited by 24
Distinct iron homeostasis in C57BL/6 and Balb/c mouse strains
Saha, P., Xiao, X., Li, Y., Golonka, R. M., Abokor, A. A., Yeoh, B. S., & Vijay–Kumar, M. (2020) · Physiological Reports · doi:10.14814/phy2.14441 · Cited by 21
What’s Important and New in Hemochromatosis?
Brissot, P., & Brissot, É. (2020) · Clinical Hematology International · doi:10.2991/chi.k.200726.001 · Cited by 21
A Comprehensive Review on the Roles of Metals Mediating Insect–Microbial Pathogen Interactions
Khan, S., & Lang, M. (2023) · Metabolites · doi:10.3390/metabo13070839 · Cited by 22
Li, T., Du, Y., Yao, H., Zhao, B., Wang, Z., Chen, R., Ji, Y., & Du, M. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116202 · Cited by 22
Mechanism of Ca2+ transport by ferroportin
Shen, J., Wilbon, A. S., Zhou, M., & Pan, Y. (2023) · eLife · doi:10.7554/elife.82947 · Cited by 21
Ferroptosis in Cardiovascular Diseases and Ferroptosis-Related Intervention Approaches
Zhou, X., Wang, H., Yan, B., Nie, X., Chen, Q., Yang, X., Lei, M., Guo, X., Ouyang, C., & Ren, Z. (2024) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-024-07642-5 · Cited by 22
The Ferroxidase Hephaestin in Lung Cancer: Pathological Significance and Prognostic Value
Zacchi, P., Belmonte, B., Mangogna, A., Morello, G., Scola, L., Martorana, A., & Borelli, V. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.638856 · Cited by 20
Yang, M., Yu, H., Xu, K., Xie, J., Zheng, H., Feng, R., Wang, J., & Xu, P. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1047640 · Cited by 20
Wang, Y., Protchenko, O. V., Huber, K. D., Shakoury‐Elizeh, M., Ghosh, M. C., & Philpott, C. C. (2023) · Blood · doi:10.1182/blood.2023020504 · Cited by 22
Si, N-codoped carbon dots: preparation and application in iron overload diagnosis
He, S., Qi, S., Sun, Z., Zhu, G., Zhang, K., & Chen, W. (2018) · Journal of Materials Science · doi:10.1007/s10853-018-3150-2 · Cited by 20
Iron overload as a high risk factor for microgravity-induced bone loss
Chen, X., Yang, J., Dong, D., Lv, H., Zhao, B., Xue, Y., & Shang, P. (2019) · Acta Astronautica · doi:10.1016/j.actaastro.2019.07.034 · Cited by 20
Zhang, C., Wang, B., Zhao, X., Li, X., Lou, Z., Chen, X., & Zhang, F. (2018) · Europe PMC (PubMed Central) · Cited by 20
Targeting NRF2 to suppress ferroptosis in brain injury.
Song, S., Gao, Y., Sheng, Y., Rui, T., & Luo, C. (2021) · PubMed · doi:10.14670/hh-18-286 · Cited by 20
Winn, N. C., Wolf, E. M., Cottam, M. A., Bhanot, M., & Hasty, A. H. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00116.2021 · Cited by 21
Harrington-Kandt, R., Stylianou, E., Eddowes, L. A., Lim, P. J., Stockdale, L. K., Pinpathomrat, N., Bull, N. C., Pasricha, J., Ulaszewska, M., Beglov, Y., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191038 · Cited by 21
Self-citationUguen, K., Ka, C., Collod‐Béroud, G., Tertre, M. L., Guellec, J., Férec, C., Béroud, C., Callebaut, I., & Gac, G. L. (2023) · Human Mutation · doi:10.1155/2023/5162256 · Cited by 21
From iron-driven cell death to clot formation: The emerging role of ferroptosis in thrombogenesis
Ravari, F. K., Gorji, M. G., & Rafiei, A. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118328 · Cited by 19
Perng, V., Li, C., Klocke, C. R., Navazesh, S. E., Pinneles, D., Lein, P. J., & Ji, P. (2020) · Journal of Nutrition · doi:10.1093/jn/nxaa326 · Cited by 19
Metadata
- Authors
- Drakesmith, H., Nemeth, E., & Ganz, T.
- Affiliations
- University of Oxford (GB)
- University of California, Los Angeles (US)
- Corresponding author
- Ganz, Tomas
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2015-11
- Volume
- 22
- Issue
- 5
- Pages
- 777-787
- ISSN
- 1550-4131 (ISSN-L)
- PMC
- PMC4635047
- OpenAlex
- W2174098335
- Cited by
- 638
- References
- 110
- Citations by year
- 2026: 35 · 2025: 64 · 2024: 68 · 2023: 76 · 2022: 75 · 2021: 67 · 2020: 86 · 2019: 52 · 2018: 54 · 2017: 33 · 2016: 24 · 2015: 1
- FWCI
- 5.59
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell Metabolism (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK065029, R01DK090554, R01DK107309)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Keywords
- ferroportin, hepcidin, iron homeostasis, iron absorption, erythropoiesis, iron recycling, iron storage, iron export, membrane protein structure, host defense, oxygen utilization
- MeSH terms
- Ferroportin, Animals, Erythrocytes, Erythropoiesis, Homeostasis, Humans, Iron, Macrophages, Hepatocytes, Cation Transport Proteins, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
